Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 15 of 15
Re-Vana Therapeutics Ltd
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2016
Hold
10yr
Recurv Pharma, Inc.
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
ReNewVax
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2025
Hold
1yr
Repron Therapeutics
Claris Biotech I
Italy
Active
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2023
Hold
3yr
Reservoir Neuroscience
KIZOO Evergreen (Balance Sheet)
United States
Active
Sector
Biotech
InvestorKIZOO Technology Capital
Entry
2024
Hold
2yr
Rewind Therapeutics
Boehringer Ingelheim Venture Fund
Belgium
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2017
Hold
9yr
RiboX Therapeutics
Boehringer Ingelheim Venture Fund
China
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2021
Hold
5yr
RQ Biotechnology
LifeArc Ventures
UK
Active
Sector
Biotech
InvestorLifeArc
Entry
2022
Hold
4yr
Rubedo Life Sciences
Oscar & Paul Venture Capital Fund I
United States
Active
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Ruby Bio
Nucleus Capital II
United States
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2025
Hold
1yr
Sable Bio
MMC Ventures EIS Fund
UK
Active
Sector
Biotech
InvestorMMC Ventures
Entry
2025
Hold
1yr
Sarkana Pharma, Inc.
TVM Life Science Innovation
Canada
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
Scripta Therapeutics
Parkwalk Opportunities EIS Fund
UK
Active
Sector
Biotech
InvestorParkwalk Advisors
Entry
2025
Hold
1yr
Signatope
HTGF II
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
Silk Biomaterials
Principia III - Health
Italy
Active
Sector
Biotech
InvestorPrincipia SGR
Entry
2016
Hold
10yr
Souffle Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2025
Hold
1yr
StemTek Therapeutics
Fondo BI
Spain
Active
Sector
Biotech
InvestorSeed Capital de Bizkaia
Entry
2016
Hold
10yr
STipe Therapeutics
Wellington Partners Life Sciences
Denmark
Active
Sector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Sudo Biosciences
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2024
Hold
2yr
SwitchKine
Boehringer Ingelheim Venture Fund
Switzerland
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
Syngoi Technologies
Columbus Life Sciences Fund IV
Spain
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2023
Hold
3yr
Synthetica Pioneering
Boehringer Ingelheim Venture Fund
China
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
T-Curx
Seedfonds Bayern
Germany
Active
Sector
Biotech
InvestorBayern Kapital
Entry
2025
Hold
1yr
T-One Therapeutics
Utopia SIS
Italy
Active
Sector
Biotech
InvestorUtopia SIS
Entry
2022
Hold
4yr
T7 Therapeutics
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
TECregen
Boehringer Ingelheim Venture Fund
Switzerland
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Ternary Therapeutics
Daphni Blue
France
Active
Sector
Biotech
InvestorDaphni
Entry
2025
Hold
1yr
Thelior Bio
Oxford Science Enterprises Balance Sheet
UK
Active
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2025
Hold
1yr
TIBEAY Biosciences
MIG Fonds 18
Netherlands
Active
Sector
Biotech
InvestorMIG Capital
Entry
2026
Hold
0yr
Tolemy Bio
Big Sur Ventures Fund
United Kingdom
Active
Sector
Biotech
InvestorBig Sur Ventures
Entry
2026
Hold
0yr
TolemyBio
JME Ventures IV
Spain
Active
Sector
Biotech
InvestorJME Ventures
Entry
2026
Hold
0yr
Tribune Therapeutics
LifeArc Ventures
Sweden
Active
Sector
Biotech
InvestorLifeArc
Entry
2025
Hold
1yr
TRIM TX
HTGF IV
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2025
Hold
1yr
Twogee Biotech
Seedfonds Bayern
Germany
Active
Sector
Biotech
InvestorBayern Kapital
Entry
2026
Hold
0yr
Umecrine Mood
Rosetta Capital IV
Sweden
Active
Sector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
Univercells
AFB Fund II
Belgium
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2022
Hold
4yr
VarmX
Ysios BioFund III
NL
Active
Sector
Biotech
InvestorYsios Capital Partners
Entry
2020
Hold
6yr
Vesigen Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Vespina Life Sciences, Inc.
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
Vincere Biosciences
Oscar & Paul Venture Capital Fund I
United States
Active
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2025
Hold
1yr